2024 Clinical Outcome Assessment Program Annual Meeting

Registration is closed!
2024 Clinical Outcome Assessment Program Annual Meeting

(Formerly, the Annual PRO Consortium Workshop)

On April 17-18, 2024, the 2024 Clinical Outcome Assessment Annual Meeting (formerly, the Annual PRO Consortium Workshop) will be held at the Bethesda North Marriott & Conference Center, Rockville, MD. As announced during the 14th Annual PRO Consortium Workshop held in April 2023, we are transitioning to a Clinical Outcome Assessment (COA) Program-focused meeting. Topics to be covered/addressed during this year’s event include:

  • Update on FDA’s Clinical Outcome Assessment (COA) Qualification Program and other FDA initiatives
  • eCOA and digital health technologies (DHTs) in oncology: realizing the digital dividend
  • Mitigating challenges in observer-reported outcome assessments: sharing lessons learned from across the COA Program
  • Leveraging digital health technology and partnership opportunities to measure clinical outcomes that matter
  • COAs used in trial entry, stratification, and endpoints: evidence and implications to ensure they’re fit for their purpose
  • PRO measurement now and into the future: multi-stakeholder perspectives regarding the optimization of PRO data in the decision-making process across the healthcare continuum
  • High-level summaries of the ongoing activities and recent accomplishments of the COA Program including updates from the PRO Consortium, Rare Disease COA Consortium, and eCOA Consortium

All meeting slide decks, posters, and recordings will be posted to this site by no later than May 31, 2024.